VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 200 filers reported holding VAXCYTE INC in Q2 2023. The put-call ratio across all filers is 4.14 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,103,322 | -7.2% | 62,141 | -30.3% | 0.01% | -78.0% |
| Q1 2023 | $3,342,579 | -53.5% | 89,183 | -40.6% | 0.05% | -61.8% |
| Q4 2022 | $7,193,267 | +405.9% | 150,016 | +153.1% | 0.13% | +385.2% |
| Q3 2022 | $1,422,000 | -59.9% | 59,260 | -63.7% | 0.03% | -72.4% |
| Q2 2022 | $3,550,000 | +111.7% | 163,125 | +134.9% | 0.10% | +117.8% |
| Q1 2022 | $1,677,000 | – | 69,452 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 4,168,718 | $82,124,000 | 28.36% |
| Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $37,277,000 | 21.71% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,405,421 | $27,757,000 | 8.90% |
| FRAZIER MANAGEMENT LLC | 2,309,554 | $45,614,000 | 3.66% |
| RA Capital Management | 3,865,808 | $76,350,000 | 1.15% |
| TPG Group Holdings (SBS) Advisors, Inc. | 4,558,475 | $90,030,000 | 1.05% |
| Soleus Capital Management, L.P. | 293,650 | $5,800,000 | 1.04% |
| Opaleye Management Inc. | 357,800 | $7,067,000 | 1.04% |
| SABBY MANAGEMENT, LLC | 178,992 | $3,535,000 | 0.69% |
| Penn Mutual Asset Management | 22,227 | $439,000 | 0.50% |